Fresenius Medical Care Corporation (FMS)

Fresenius Medical Care Corporation (NYSE: FMS) is a depositary receipt representing common stock of Fresenius Medical Care AG, a healthcare company focused on dialysis and related services for people with renal disease. Through its Care Delivery and Care Enablement segments, the company provides dialysis treatment, laboratory and diagnostic services, patient support, and hospital-based dialysis services in the United States for patients with end-stage renal disease or acute kidney failure. It also develops, manufactures, and distributes kidney care products such as hemodialysis machines, peritoneal dialysis systems and solutions, bloodlines, renal pharmaceuticals, and water-treatment systems. The company serves customers in Germany, the United States, and other international markets, with products and services sold through clinics, hospitals, distributors, and direct sales channels. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-FMS
$33.22
34.5% Upside
Undervalued
$25.68
4.0% Upside
Fair
Great
0.61
2.5%
August 4, 2026
12.2x
0.9x
0.6x
12.824 B
24.915 B
47.5%
68.4%
7.9
44.7%
189.0%
Valuation • Fair Value

Fresenius Medical Care Corporation (NYSE-FMS) Fair Value by Valuation Model

Compare the primary fair value estimate for Fresenius Medical Care Corporation (NYSE-FMS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$33.22

Estimated upside of 34.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$43.88

Discounted cash flow valuation reference.

Ben Graham Formula Value

$22.41

Classic Ben Graham valuation formula reference.

DDM Fair Value

$25.71

Dividend discount model valuation reference.

EPV Fair Value

$15.40

Earnings power value estimate.

Comps Fair Value

$29.81

Comparable-company valuation reference.

Analyst Price Target

$25.68

Analysts imply upside of 4.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Fresenius Medical Care Corporation (NYSE-FMS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Fresenius Medical Care Corporation (NYSE-FMS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

22.374 B

Current operating scale indicator.

Revenue Forecast

32.715 B

Forward revenue estimate.

EBITDA

2.996 B

Current operating profitability reference.

EBITDA Forecast

4.032 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Fresenius Medical Care Corporation (NYSE-FMS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Fresenius Medical Care Corporation (NYSE-FMS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.82

No elevated caution signal from this screen.

Altman Z-Score

7.9

Relatively strong balance-sheet zone.

FCF / Net Income

189.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Fresenius Medical Care Corporation (NYSE-FMS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Fresenius Medical Care Corporation (NYSE-FMS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 4, 2026

Days to Earnings

14

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.5%

Income yield reference.

Upcoming Dividend

0.61

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

44.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Fresenius Medical Care Corporation (NYSE-FMS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Fresenius Medical Care Corporation (NYSE-FMS) Stock Forecast & Technical Outlook

Review Fresenius Medical Care Corporation (NYSE-FMS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Fresenius Medical Care Corporation (NYSE-FMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Fresenius Medical Care Corporation (NYSE-FMS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Fresenius Medical Care Corporation (NYSE-FMS) has a Hold consensus, with 1 buy, 3 hold and 1 sell recommendations in the current data set.

Buy 1
Hold 3
Sell 1
FAQ Fast Investor Answers

Fresenius Medical Care Corporation (NYSE-FMS) Stock FAQ

Quick answers about Fresenius Medical Care Corporation (NYSE-FMS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$33.22
Estimated upside 34.5%
Valuation Rating
Undervalued
Estimated upside of 34.5%
Analyst Target
$25.68
Implied upside 4.0%
Financial Health
Great
Current financial-health read

The current fair value estimate for Fresenius Medical Care Corporation (NYSE-FMS) is $33.22. This implies an estimated upside of 34.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 34.5% versus the current market price.

The available analyst price target for Fresenius Medical Care Corporation (NYSE-FMS) is $25.68. The analyst target implies estimated upside of 4.0%.

The current financial health read for Fresenius Medical Care Corporation (NYSE-FMS) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Fresenius Medical Care Corporation (NYSE-FMS) is August 4, 2026.

Based on the current data, dividend yield is 2.5%, upcoming dividend amount is 0.61.

The current P/E ratio listed for Fresenius Medical Care Corporation (NYSE-FMS) is 12.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Fresenius Medical Care Corporation is 12.824 B.

The current enterprise value listed for Fresenius Medical Care Corporation is 24.915 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Fresenius Medical Care Corporation is NYSE-FMS, and the stock is listed on NYSE.

Fresenius Medical Care Corporation (NYSE-FMS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Fresenius Medical Care Corporation is 47.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Fresenius Medical Care Corporation is 68.4%. Free float helps investors understand how much of the share base is available for public trading.